Regulation

Oregon’s Drug Decriminalization Creates Unfunded Mandate for Treatment Providers

Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...

Amid Growth, Pinnacle CEO Pushes for Methadone MAT Flexibilities

The past several months have been devastating for many behavioral health providers. The COVID-19 pandemic has caused widespread...

How the Pandemic Accelerated Telehealth Adoption

The coronavirus pandemic has reshaped the behavioral health landscape, creating both challenges and opportunities for mental health care...

Virtual Pediatric Behavioral Health Provider Brightline Raises $20 Million

Brightline, a Palo Alto-based startup specializing in virtual pediatric behavioral health care, recently announced a $20 million Series...

Discovery Behavioral Health Expands With Two New Adolescent Mental Health Centers

Discovery Behavioral Health, a portfolio company of Webster Equity Partners, has made another significant move in expanding its...
spot_img

Addressing the Health Care Needs of Older Americans: A Call for Change

As the aging population in America continues to grow, the health care system must evolve to meet the increasingly complex needs of older adults....

How State Policies Are Shaping the Future of Telehealth in Substance Use Disorder Treatment

The COVID-19 pandemic reshaped how healthcare is delivered across the U.S.—and one of the most dramatic shifts occurred in behavioral health. As in-person care...

The Rise of Stimulant and Antidepressant Prescriptions: Exploring the Role of Telehealth and Shifting Trends in Medication Use

In recent years, the landscape of prescription medications has undergone notable changes, particularly with respect to stimulants and antidepressants. A new study published in...

Brittany Hines: A Visionary Leader in Behavioral Health

Brittany Hines, Director of Product for Benji Health, has been named a 2024 Future Leader by Behavioral Health Business (BHB). This prestigious recognition is...

A New Bill in Congress Aims to Address Medicaid’s IMD Exclusion for Substance Use Disorder Treatment

For over half a century, one of the most significant barriers to accessing residential treatment for substance use disorder (SUD) in the United States...

Ensuring Effective Treatment for Opioid Use Disorder: Strengthening Oversight of Opioid Treatment Programs Compliance

Opioid Treatment Programs (OTPs) are the cornerstone of medication-assisted treatment for individuals suffering from Opioid Use Disorder (OUD). These programs provide evidence-based medications, such...
spot_img